NRIX Sale Disclosure
Van Houte Hans · SEC Form 4 · Filed Nov 4, 2026
Sale
Calculated transaction value
$50.76K
Van Houte Hans Chief Financial Officer
NRIX
Nurix Therapeutics
NRIX
Transaction date
Nov 4, 2026
Public filing date
Nov 4, 2026
Filing lag
Filed same day
NRIX daily price context
Close on/before transaction
$15.95
Nov 4, 2026
First close after public filing
$14.84
Nov 5, 2026
Return after filing · so far
+3.1%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,300 shares @ $15.38
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001817217-26-000016
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$74.56K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Nurix Therapeutics, Inc. NRIX Current | Sale | Nov 4, 2026 | $50.76K |
| Nurix Therapeutics, Inc. NRIX | Sale | Nov 4, 2026 | $23.8K |